Phase IV study of national extension of HeberPAG use in patients with basal cell carcinoma to assess effectiveness and safety at the population level

Trial Profile

Phase IV study of national extension of HeberPAG use in patients with basal cell carcinoma to assess effectiveness and safety at the population level

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Interferon-alpha-2b/interferon-gamma (Primary)
  • Indications Basal cell cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms InCarbacel-IV
  • Most Recent Events

    • 18 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top